Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease
Endocrine Abstracts · 04.03.2026
DOI: 10.1530/endoabs.116.c25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von MD Jason Kim, und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim,, M. J., Fidelman,, M. N., MD, Bergsland,, E., Tolstrup,, M. K., Ziv,, E., Alexander,, M. E., Aguirre, & Gonzalez, M. A. (2026). Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease. Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.c25
Vancouver
Kim, MJ, Fidelman, MN, MD, Bergsland, E, Tolstrup, MK, Ziv, E, et al. Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease. Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.c25
BibTeX
@article{Kim2026,
author = {Kim,, MD Jason and Fidelman,, MD Nicholas and MD and Bergsland,, Emily and Tolstrup,, MD Kirsten and Ziv,, Etay and Alexander,, MD Erica and Aguirre and Gonzalez, MD Adrian},
title = {Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease},
journal = {Endocrine Abstracts},
year = {2026},
doi = {10.1530/endoabs.116.c25}
}
EUVIMED